A new Harvard research study suggests that vascular surgeons should consider insulin dependency when determining treatment for chronic limb-threatening ischemia in patients with diabetes.
Dr. Daugherty, associate vice president at the University of Kentucky, will discuss his research at the SVS Vascular Research Initiatives Conference in May. His talk, "Angiotensin II and Cellular Complexity of the Aorta, a Recipe for Aneurysmal Location," is the second annual Alexander W. Clowes Distinguished Lecture. Register today for the Vascular Research Initiatives Conference.
The program is taking shape and registration is now open for an important SVS research-oriented event, the Vascular Research Initiatives Conference. It will be held May 9 at the Hilton San Francisco Union Square.
LONG-TERM MORTALITY BENEFIT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA UNDERGOING VASCULAR INTERVENTION, Journal of Vascular Surgery, March 2018
With her research, Omaida C. Velazquez, MD, searches for "what’s missing today that we can make available for tomorrow’s patients." She presented at the 2017 Vascular Research Initiatives Conference, discussing gene therapy and peripheral arterial disease. Abstracts are being accepted through Jan. 10, 2018, for the May 9 conference.
Does the anemic – but high cardiac risk – patient need a blood transfusion, or not?
SVS member Dr. Panos Kougias is leading a study on the best transfusion approach when treating patients at high cardiac risk who become anemic postoperatively.
Large national study finds vascular surgery for thoracic outlet syndrome is safe
At the 2017 Vascular Annual Meeting (May 31-June 3), the SVS Foundation awarded a number of basic and clinical research grants.
“Effects of Hospital Safety-Net Burden and Hospital Volume on Failure to Rescue After Open Abdominal Aortic Surgery,” Journal of Vascular Surgery, August, 2017.